Burning Rock Biotech Ltd (BNR)
7.80
0.00 (0.00%)
USD |
NASDAQ |
Jun 12, 16:00
7.80
0.00 (0.00%)
Pre-Market: 20:00
Burning Rock Biotech Enterprise Value: -0.4473M for June 12, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 12, 2024 | -0.4473M |
| June 11, 2024 | -0.4473M |
| June 10, 2024 | -0.4473M |
| June 07, 2024 | -0.4473M |
| June 06, 2024 | -0.4473M |
| June 05, 2024 | -2.089M |
| June 04, 2024 | -3.628M |
| June 03, 2024 | -3.628M |
| May 31, 2024 | -7.115M |
| May 30, 2024 | -7.115M |
| May 29, 2024 | -3.012M |
| May 28, 2024 | -3.012M |
| May 24, 2024 | -3.012M |
| May 23, 2024 | -2.807M |
| May 22, 2024 | -2.499M |
| May 21, 2024 | -1.884M |
| May 20, 2024 | -0.6525M |
| May 17, 2024 | 4.682M |
| May 16, 2024 | 1.912M |
| May 15, 2024 | 3.964M |
| May 14, 2024 | 1.604M |
| May 13, 2024 | 2.117M |
| May 10, 2024 | 0.8863M |
| May 09, 2024 | -0.4986M |
| May 08, 2024 | -1.473M |
| Date | Value |
|---|---|
| May 07, 2024 | 0.5786M |
| May 06, 2024 | 2.948M |
| May 03, 2024 | 2.323M |
| May 02, 2024 | -2.643M |
| May 01, 2024 | -3.748M |
| April 30, 2024 | -3.002M |
| April 29, 2024 | 5.349M |
| April 26, 2024 | 6.734M |
| April 25, 2024 | 6.739M |
| April 24, 2024 | 3.738M |
| April 23, 2024 | 7.657M |
| April 22, 2024 | 7.760M |
| April 19, 2024 | -6.602M |
| April 18, 2024 | 1.604M |
| April 17, 2024 | 1.604M |
| April 16, 2024 | -2.489M |
| April 15, 2024 | 1.594M |
| April 12, 2024 | -2.499M |
| April 11, 2024 | -2.499M |
| April 10, 2024 | -3.658M |
| April 09, 2024 | -4.551M |
| April 08, 2024 | -7.505M |
| April 05, 2024 | -7.628M |
| April 04, 2024 | -7.167M |
| April 03, 2024 | -1.596M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-24.63M
Minimum
Jun 13 2022
3.799B
Maximum
Feb 22 2021
969.97M
Average
198.37M
Median
May 09 2022
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.011B |
| CASI Pharmaceuticals Inc | 42.07M |
| Zai Lab Ltd | 1.374B |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | 39.40M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.99M |
| Revenue (Quarterly) | 17.56M |
| Total Expenses (Quarterly) | 35.14M |
| EPS Diluted (Quarterly) | -1.663 |
| Gross Profit Margin (Quarterly) | 68.22% |
| Profit Margin (Quarterly) | -96.76% |
| Earnings Yield | -103.2% |
| Normalized Earnings Yield | -103.13 |